DeLLphi-306 trial: a phase 3 study of tarlatamab after concurrent chemoradiotherapy in limited-stage small cell lung cancer
Dowlati, A. Hummel, H. D. Paz-Ares, L. Blackhall, Fiona Chiang, A. Goldman, J. Izumi, H. Mok, T. Sands, J. Martinez, P.
Dowlati, A.
Hummel, H. D.
Paz-Ares, L.
Blackhall, Fiona
Chiang, A.
Goldman, J.
Izumi, H.
Mok, T.
Sands, J.
Martinez, P.
Citations
Altmetric:
Abstract
Description
Date
2024
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Dowlati A, Hummel HD, Paz-Ares L, Blackhall F, Chiang A, Goldman J, et al. DeLLphi-306 Trial: A Phase 3 Study of Tarlatamab after Concurrent Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer. JOURNAL OF THORACIC ONCOLOGY. 2024 OCT;19(10):S206-S. PubMed PMID: WOS:001337925601140. English.